NASDAQ:AEZS
$3.73
(
1.08%
)
Friday, 27th Jan 2023
AEterna Zentaris Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $2.89 | $3.94 | Friday, 27th Jan 2023 AEZS stock ended at $3.73. This is 1.08% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 2.29% from a day low at $3.72 to a day high of $3.80. |
| 90 days | $2.89 | $4.30 | |
| 52 weeks | $2.89 | $10.99 |
Historical AEterna Zentaris Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $3.74 | $3.80 | $3.72 | $3.73 | 9 747 |
| 2023-01-26 | $3.74 | $3.84 | $3.66 | $3.69 | 15 929 |
| 2023-01-25 | $3.68 | $3.85 | $3.68 | $3.74 | 13 735 |
| 2023-01-24 | $3.81 | $3.90 | $3.72 | $3.72 | 6 840 |
| 2023-01-23 | $3.84 | $3.86 | $3.79 | $3.84 | 12 690 |
| 2023-01-20 | $3.84 | $3.89 | $3.78 | $3.86 | 17 100 |
| 2023-01-19 | $3.82 | $3.89 | $3.82 | $3.87 | 8 032 |
| 2023-01-18 | $3.82 | $3.94 | $3.77 | $3.89 | 39 600 |
| 2023-01-17 | $3.93 | $3.93 | $3.71 | $3.75 | 20 932 |
| 2023-01-13 | $3.70 | $3.82 | $3.70 | $3.75 | 13 810 |
| 2023-01-12 | $3.48 | $3.72 | $3.48 | $3.66 | 14 000 |
| 2023-01-11 | $3.52 | $3.68 | $3.51 | $3.58 | 6 839 |
| 2023-01-10 | $3.50 | $3.70 | $3.50 | $3.58 | 4 100 |
| 2023-01-09 | $3.57 | $3.62 | $3.55 | $3.62 | 13 962 |
| 2023-01-06 | $3.37 | $3.59 | $3.37 | $3.58 | 6 000 |
| 2023-01-05 | $3.24 | $3.50 | $3.22 | $3.42 | 3 380 |
| 2023-01-04 | $3.22 | $3.33 | $3.12 | $3.33 | 5 694 |
| 2023-01-03 | $3.25 | $3.25 | $3.12 | $3.22 | 15 909 |
| 2022-12-30 | $3.02 | $3.20 | $2.98 | $3.18 | 28 378 |
| 2022-12-29 | $2.93 | $3.07 | $2.89 | $3.04 | 27 895 |
| 2022-12-28 | $3.09 | $3.23 | $2.96 | $3.02 | 43 538 |
| 2022-12-27 | $3.25 | $3.27 | $3.08 | $3.08 | 16 347 |
| 2022-12-23 | $3.27 | $3.27 | $3.19 | $3.23 | 4 865 |
| 2022-12-22 | $3.17 | $3.22 | $3.15 | $3.20 | 17 774 |
| 2022-12-21 | $3.16 | $3.28 | $3.14 | $3.22 | 53 295 |
| 2022-12-20 | $3.20 | $3.27 | $3.20 | $3.23 | 8 996 |
| 2022-12-19 | $3.29 | $3.32 | $3.25 | $3.25 | 8 515 |
| 2022-12-16 | $3.24 | $3.33 | $3.24 | $3.28 | 20 607 |
| 2022-12-15 | $3.47 | $3.55 | $3.28 | $3.33 | 50 108 |
| 2022-12-14 | $3.61 | $3.72 | $3.36 | $3.58 | 31 831 |
| 2022-12-13 | $3.87 | $3.87 | $3.64 | $3.65 | 19 244 |
| 2022-12-12 | $3.68 | $3.99 | $3.68 | $3.78 | 26 346 |
| 2022-12-09 | $3.75 | $4.00 | $3.75 | $3.86 | 38 795 |
| 2022-12-08 | $3.78 | $3.90 | $3.70 | $3.87 | 27 156 |
| 2022-12-07 | $3.73 | $3.74 | $3.67 | $3.70 | 11 096 |
| 2022-12-06 | $3.88 | $3.94 | $3.75 | $3.77 | 18 656 |
| 2022-12-05 | $3.82 | $3.98 | $3.80 | $3.84 | 9 978 |
| 2022-12-02 | $3.81 | $3.97 | $3.81 | $3.96 | 3 106 |
| 2022-12-01 | $3.90 | $3.90 | $3.68 | $3.88 | 8 990 |
| 2022-11-30 | $3.71 | $3.98 | $3.66 | $3.92 | 27 701 |
| 2022-11-29 | $3.62 | $3.95 | $3.62 | $3.76 | 14 340 |
| 2022-11-28 | $3.83 | $3.83 | $3.65 | $3.65 | 12 834 |
| 2022-11-25 | $3.80 | $3.80 | $3.67 | $3.74 | 10 685 |
| 2022-11-23 | $3.59 | $3.82 | $3.59 | $3.78 | 4 584 |
| 2022-11-22 | $3.53 | $3.74 | $3.52 | $3.73 | 6 220 |
| 2022-11-21 | $3.63 | $3.74 | $3.55 | $3.66 | 3 893 |
| 2022-11-18 | $3.74 | $3.76 | $3.57 | $3.67 | 3 905 |
| 2022-11-17 | $3.67 | $3.75 | $3.63 | $3.72 | 2 323 |
| 2022-11-16 | $3.80 | $3.83 | $3.60 | $3.60 | 2 953 |
| 2022-11-15 | $3.64 | $3.78 | $3.64 | $3.78 | 14 093 |
About AEterna Zentaris Inc.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. T... AEZS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
